EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Microglial activation without peripheral immune cell infiltration characterises mouse and human cerebral small vessel disease

Tushar Deshpande iD, Melanie-Jane Hannocks, Kishan Kapupara, Sai Kiran Reddy Samawar, Lydia Wachsmuth, Cornelius Faber, Colin Smith iD, Joanna Wardlaw, Lydia Sorokin

Neuropathology and Applied Neurobiology · 2024-12 · 50 (6)

DOI: 10.1111/nan.13015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropathology and Applied Neurobiology, online erschienen am 14.11.2024. Verfasst von Tushar Deshpande und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Physiological Chemistry and Pathobiochemistry and Cells-in-Motion Interfaculty Centre (CiMIC), University of Muenster, Muenster, Germany. Hauptthemen laut MEDLINE: Cerebral Small Vessel Diseases, Microglia, Disease Models, Animal. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: SVDs@target consortium (funded by the European Union's Horizon 2020 Research and Innovation Programme), Marie Sklodowska-Curie International Training Network ENTRAIN, German Research Foundation (DFG).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Cerebral small vessel diseases (SVDs) involve diverse pathologies of the brain's small blood vessels, leading to cognitive deficits. Cerebral magnetic resonance imaging (MRI) reveals white matter hyperintensities (WMHs), lacunes, microbleeds and enlarged perivascular spaces in SVD patients. Although correlations of MRI and histopathology help to understand the pathogenesis of SVD, they do not explain disease progression. Mouse models, both genetic and sporadic, are valuable for studying SVD, but their resemblance to clinical SVD is unclear. The study examined similarities and differences between mouse models of SVDs and human nonamyloid SVD specimens.

Methods

We analysed four mouse models of SVD (hypertensive BPH mice, Col4a1 mutants, Notch3 mutants and Htra1 −/− mice) at different stages for changes in myelin, blood‐brain barrier (BBB) markers, immune cell populations and immune activation. The observations from mouse models were compared with human SVD specimens from different regions, including the periventricular, frontal, central and occipital white matter. Postmortem MRI followed by MBP immunostaining was used to identify white matter lesions (WMLs).

Results

Only Notch3 mutant and hypertensive BPH mice showed significant changes in myelin basic protein (MBP) immunostaining, correlating with MRI patterns. These changes were linked to altered microglial morphology and focal plasma protein staining around blood vessels, without peripheral immune cell infiltration. In human specimens, both normal‐appearing white matter (NAWM) and WMLs lacked peripheral cell infiltration. However, WMLs displayed altered microglial morphology, reduced myelin staining and occasional fibrinogen staining around arterioles and venules.

Conclusions

Our data show that Notch3 mutants and hypertensive BPH/2J mice recapitulate several features of human SVD, including microglial activation, focal sites of demyelination and perivascular plasma protein leakage without peripheral immune cell infiltration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebral Small Vessel DiseasesMicrogliaDisease Models, AnimalAnimalsHumansMiceBrainMaleWhite MatterBlood-Brain BarrierMagnetic Resonance ImagingFemale

Stichwörter der Autor:innen

cerebral small vessel diseasemicroglial activationmouse models of SVDperipheral immune cellspostmortem MRI‐histopathology correlations

Autor:innen und Institutionen

  • Institute of Physiological Chemistry and Pathobiochemistry and Cells-in-Motion Interfaculty Centre (CiMIC), University of Muenster, Muenster, Germany.
  • Clinic of Radiology, University of Muenster, Muenster, Germany.
  • Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
  • Centre for Clinical Brain Sciences, UK Dementia Research Institute, University of Edinburgh, Edinburgh, UK.

ORCID-Profile: Tushar Deshpande, Colin Smith

Förderung

  • SVDs@target consortium (funded by the European Union's Horizon 2020 Research and Innovation Programme)
  • Marie Sklodowska-Curie International Training Network ENTRAIN
  • German Research Foundation (DFG)
  • UK Dementia Research Institute funded by the UK MRC
  • Alzheimer's Society and Alzheimer Research UK
  • IZKF Münster
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Deshpande, T., Hannocks, M. J., Kapupara, K., Samawar, S. K. R., Wachsmuth, L., Faber, C., Smith, C., Wardlaw, J., & Sorokin, L. (2024). Microglial activation without peripheral immune cell infiltration characterises mouse and human cerebral small vessel disease. Neuropathology and Applied Neurobiology, 50(6). https://doi.org/10.1111/nan.13015

Vancouver

Deshpande T, Hannocks MJ, Kapupara K, Samawar SKR, Wachsmuth L, Faber C, et al. Microglial activation without peripheral immune cell infiltration characterises mouse and human cerebral small vessel disease. Neuropathology and Applied Neurobiology. 2024;50(6). doi:10.1111/nan.13015

BibTeX
@article{Deshpande2024,
  author = {Deshpande, Tushar and Hannocks, Melanie-Jane and Kapupara, Kishan and Samawar, Sai Kiran Reddy and Wachsmuth, Lydia and Faber, Cornelius and Smith, Colin and Wardlaw, Joanna and Sorokin, Lydia},
  title = {Microglial activation without peripheral immune cell infiltration characterises mouse and human cerebral small vessel disease},
  journal = {Neuropathology and Applied Neurobiology},
  year = {2024},
  volume = {50},
  number = {6},
  doi = {10.1111/nan.13015}
}
Kostenlos starten →